Skip Header
Important information: The value of investments can go down as well as up so you may get back less than you invest. Investors should note that the views expressed may no longer be current and may have already been acted upon. This is a third-party news feed and may not reflect Fidelity’s views.

London pre-open: Stocks seen up as Trump announces Iran-Israel ceasefire

(Sharecast News) - London stocks were set to gain at the open on Tuesday after US president Donald Trump announced that a ceasefire between Israel and Iran has taken effect. The FTSE 100 was called to open around 45 points higher.

Ipek Ozkardeskaya, senior analyst at Swissquote Bank, said: "Middle East tensions suddenly waned after Iran fired missiles at a US air base in Qatar - having reportedly informed the US in advance. As a result, the missiles were intercepted. President Trump called Iran's move 'weak' and announced a few hours ago that Israel and Iran had reached a ceasefire agreement.

"A surprisingly swift development. Once again, Iran appears to have retaliated just enough to save face - without triggering broader escalation. Tensions will likely ease from here if Israel reciprocates. However, it remains unclear whether an actual ceasefire is in place, as missiles reportedly continue to be fired across the border. Iran has said it will stop if Israel does, but Israel has yet to make a formal statement."

In corporate news, recruiter SThree reported a drop in first-half net fees as it pointed to continued softness in new business across both the contract and permanent segments.

In the half year to 31 May, group net fees declined 14% to £159.1m in an "ongoing challenging trading environment".

Elsewhere, Rio Tinto announced a joint investment of $1.61bn with Hancock Prospecting to develop the Hope Downs 2 iron ore project in Western Australia's Pilbara region.

The mine is expected to produce 31 million tonnes of ore a year.

Drugmaker AstraZeneca said that Datroway has been approved in the US for patients with previously treated advanced EGFR-mutated non-small cell lung cancer.

AstraZeneca also noted that Datroway was the "first and only" TROP2-directed therapy approved for the treatment of lung cancer in the US.

Share this article

Related Sharecast Articles

London open: Stocks edge down as miners hit by falling copper prices
(Sharecast News) - London stocks edged lower in early trade on Friday after the top-flight index hit fresh highs in the previous session, with miners under the cosh as copper prices fell.
London close: Stocks end flat as investors pause for breath; miners slump
(Sharecast News) - London stocks ended flat on Friday as investors paused for breath following record highs earlier in the week and ahead of the long weekend in the US, with miners under the cosh as copper prices fell.
London close: Stocks end flat as investors pause for breath; miners slump
(Sharecast News) - London stocks ended flat on Friday as investors paused for breath following record highs earlier in the week and ahead of the long weekend in the US, with miners under the cosh as copper prices fell.
London pre-open: Stocks to nudge lower after record highs
(Sharecast News) - London stocks were set to edge lower at the open on Friday after the top-flight index hit a fresh record high in the previous session.

Important information: This information is not a personal recommendation for any particular investment. If you are unsure about the suitability of an investment you should speak to one of Fidelity’s advisers or an authorised financial adviser of your choice. When you are thinking about investing in shares, it’s generally a good idea to consider holding them alongside other investments in a diversified portfolio of assets. Past performance is not a reliable indicator of future returns.

Award-winning online share dealing

Search, compare and select from thousands of shares.

Expert insights into investing your money

Our team of experts explore the world of share dealing.